Literature DB >> 2391587

QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma.

E A Sankey1, L More, A P Dhillon.   

Abstract

Kaposi's sarcomas are seen more commonly in routine histopathology laboratories since the advent of the more widespread and aggressive variant of the disease associated with HIV infection. Distinguishing nodular lesions from other spindle cell and vascular tumours can sometimes be difficult. Immunohistochemistry has been disappointing as a diagnostic aid, often requiring special fixation or frozen tissue and even then, staining of spindle cells has been variable. We describe the use of the new IgG1 mouse monoclonal antibody raised against human placental endothelial cells, QBEnd/10, on routine formalin-fixed, paraffin-embedded tissue. A retrospective study was performed on 22 Kaposi's sarcomas of skin including patch, plaque, and nodular lesions and compared with 38 other vascular and spindle cell tumours from skin. All sections were stained with haematoxylin and eosin, QBEnd/10, Ulex europaeus agglutinin 1 (UEA-1) and for factor VIII-related antigen (FVIIIRAg). The results demonstrate that spindle cells in lesions from Kaposi's sarcomas, but not other vascular or spindle cell tumours, immunostain clearly with QBEnd/10. Immunostaining for FVIIIRAg shows only weak and irregular positivity of the spindle cells, whilst staining with UEA-1 is consistently negative. We find that immunostaining with QBEnd/10 aids the diagnosis of Kaposi's sarcomas and allows their distinction from other spindle cell neoplasms of skin in routinely processed material.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391587     DOI: 10.1002/path.1711610315

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.

Authors:  E Poblet; F Gonzalez-Palacios; F J Jimenez
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

2.  Immunostaining for CD31 and CD34 in Kaposi sarcoma.

Authors:  R Russell Jones; G Orchard; B Zelger; E Wilson Jones
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

3.  Lymphatic differentiation in classic Kaposi's sarcoma: patterns of D2-40 immunoexpression in the course of tumor progression.

Authors:  Nilufer Onak Kandemir; Figen Barut; Banu Dogan Gun; Sevinc Hallac Keser; Nimet Karadayi; Mustafa Gun; Sukru Oguz Ozdamar
Journal:  Pathol Oncol Res       Date:  2011-04-10       Impact factor: 3.201

Review 4.  Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders.

Authors:  S Goerdt; C Sorg
Journal:  Clin Investig       Date:  1992-02

5.  Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro.

Authors:  S Goerdt; R Bhardwaj; C Sorg
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

6.  Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.

Authors:  Y M Zhang; S Bachmann; C Hemmer; J van Lunzen; A von Stemm; P Kern; M Dietrich; R Ziegler; R Waldherr; P P Nawroth
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

7.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Authors:  G Barillari; R Gendelman; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours.

Authors:  I Kuzu; R Bicknell; A L Harris; M Jones; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

9.  Factor-XIIIa-expressing dermal dendrocytes in Kaposi's sarcoma. A comparison between classical and immunosuppression-associated types.

Authors:  J Kanitakis; M Roca-Miralles
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.

Authors:  G M Boxer; R H Begent; A M Kelly; P J Southall; S B Blair; N A Theodorou; P M Dawson; J A Ledermann
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.